187 related articles for article (PubMed ID: 22109665)
1. PET imaging of EGF receptors using [18F]FBEM-EGF in a head and neck squamous cell carcinoma model.
Li W; Niu G; Lang L; Guo N; Ma Y; Kiesewetter DO; Backer JM; Shen B; Chen X
Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):300-8. PubMed ID: 22109665
[TBL] [Abstract][Full Text] [Related]
2. PET of EGFR expression with an 18F-labeled affibody molecule.
Miao Z; Ren G; Liu H; Qi S; Wu S; Cheng Z
J Nucl Med; 2012 Jul; 53(7):1110-8. PubMed ID: 22689926
[TBL] [Abstract][Full Text] [Related]
3. A thiol-reactive 18F-labeling agent, N-[2-(4-18F-fluorobenzamido)ethyl]maleimide, and synthesis of RGD peptide-based tracer for PET imaging of alpha v beta 3 integrin expression.
Cai W; Zhang X; Wu Y; Chen X
J Nucl Med; 2006 Jul; 47(7):1172-80. PubMed ID: 16818952
[TBL] [Abstract][Full Text] [Related]
4. PET of insulinoma using ¹⁸F-FBEM-EM3106B, a new GLP-1 analogue.
Gao H; Niu G; Yang M; Quan Q; Ma Y; Murage EN; Ahn JM; Kiesewetter DO; Chen X
Mol Pharm; 2011 Oct; 8(5):1775-82. PubMed ID: 21800885
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two site-specifically (18)F-labeled affibodies for PET imaging of EGFR positive tumors.
Su X; Cheng K; Jeon J; Shen B; Venturin GT; Hu X; Rao J; Chin FT; Wu H; Cheng Z
Mol Pharm; 2014 Nov; 11(11):3947-56. PubMed ID: 24972326
[TBL] [Abstract][Full Text] [Related]
6. Imaging c-Met expression using 18F-labeled binding peptide in human cancer xenografts.
Li W; Zheng H; Xu J; Cao S; Xu X; Xiao P
PLoS One; 2018; 13(6):e0199024. PubMed ID: 29894497
[TBL] [Abstract][Full Text] [Related]
7. Site-Specific Labeling of scVEGF with Fluorine-18 for Positron Emission Tomography Imaging.
Wang H; Gao H; Guo N; Niu G; Ma Y; Kiesewetter DO; Chen X
Theranostics; 2012; 2(6):607-17. PubMed ID: 22768028
[TBL] [Abstract][Full Text] [Related]
8. Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of Epidermal Growth Factor Receptor Over-Expressing Tumors.
Goux M; Becker G; Gorré H; Dammicco S; Desselle A; Egrise D; Leroi N; Lallemand F; Bahri MA; Doumont G; Plenevaux A; Cinier M; Luxen A
Bioconjug Chem; 2017 Sep; 28(9):2361-2371. PubMed ID: 28825794
[TBL] [Abstract][Full Text] [Related]
9. 18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma.
Kiesewetter DO; Gao H; Ma Y; Niu G; Quan Q; Guo N; Chen X
Eur J Nucl Med Mol Imaging; 2012 Mar; 39(3):463-73. PubMed ID: 22170321
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of [
Li X; Hu K; Liu W; Wei Y; Sha R; Long Y; Han Y; Sun P; Wu H; Li G; Tang G; Huang S
Nucl Med Biol; 2020; 90-91():84-92. PubMed ID: 33189948
[TBL] [Abstract][Full Text] [Related]
11. Regiospecific radiolabelling of Nanofitin on Ni magnetic beads with [
Dammicco S; Goux M; Lemaire C; Becker G; Bahri MA; Plenevaux A; Cinier M; Luxen A
Nucl Med Biol; 2017 Aug; 51():33-39. PubMed ID: 28575696
[TBL] [Abstract][Full Text] [Related]
12. Preliminary biological evaluation of ¹⁸F-FBEM-Cys-Annexin V a novel apoptosis imaging agent.
Lu C; Jiang Q; Hu M; Tan C; Yu H; Hua Z
Molecules; 2015 Mar; 20(3):4902-14. PubMed ID: 25789822
[TBL] [Abstract][Full Text] [Related]
13. Early response monitoring with 18F-FDG PET and cetuximab-F(ab')2-SPECT after radiotherapy of human head and neck squamous cell carcinomas in a mouse model.
van Dijk LK; Boerman OC; Franssen GM; Lok J; Kaanders JH; Bussink J
J Nucl Med; 2014 Oct; 55(10):1665-70. PubMed ID: 25236350
[TBL] [Abstract][Full Text] [Related]
14. Insulinoma imaging with glucagon-like peptide-1 receptor targeting probe (18)F-FBEM-Cys (39)-exendin-4.
Xu Y; Pan D; Xu Q; Zhu C; Wang L; Chen F; Yang R; Luo S; Yang M
J Cancer Res Clin Oncol; 2014 Sep; 140(9):1479-88. PubMed ID: 24838847
[TBL] [Abstract][Full Text] [Related]
15. 177Lu-DO3A-HSA-Z EGFR:1907: characterization as a potential radiopharmaceutical for radionuclide therapy of EGFR-expressing head and neck carcinomas.
Hoppmann S; Qi S; Miao Z; Liu H; Jiang H; Cutler CS; Bao A; Cheng Z
J Biol Inorg Chem; 2012 Jun; 17(5):709-18. PubMed ID: 22418921
[TBL] [Abstract][Full Text] [Related]
16. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
Li CY; Klohr S; Sadick H; Weiss C; Hoermann K; Schoenberg SO; Sadick M
J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897
[TBL] [Abstract][Full Text] [Related]
17. Imaging of epidermal growth factor receptor expression in head and neck cancer with SPECT/CT and 111In-labeled cetuximab-F(ab')2.
van Dijk LK; Hoeben BA; Kaanders JH; Franssen GM; Boerman OC; Bussink J
J Nucl Med; 2013 Dec; 54(12):2118-24. PubMed ID: 24136932
[TBL] [Abstract][Full Text] [Related]
18. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer.
Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC
J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842
[TBL] [Abstract][Full Text] [Related]
19. [18F]FBEM-Z(HER2:342)-Affibody molecule-a new molecular tracer for in vivo monitoring of HER2 expression by positron emission tomography.
Kramer-Marek G; Kiesewetter DO; Martiniova L; Jagoda E; Lee SB; Capala J
Eur J Nucl Med Mol Imaging; 2008 May; 35(5):1008-18. PubMed ID: 18157531
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]